NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.63. NovaBay Pharmaceuticals shares last traded at $0.61, with a volume of 53,762 shares trading hands.
NovaBay Pharmaceuticals Stock Performance
The firm has a market cap of $2.57 million, a price-to-earnings ratio of -0.06 and a beta of 2.82.
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Further Reading
- Five stocks we like better than NovaBay Pharmaceuticals
- How to Capture the Benefits of Dividend Increases
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Stock Splits, Do They Really Impact Investors?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
